登录

[Exclusive]Nanos Medical Completed A Few Million Dollars In Series B+ Financing

作者: Mailman 2019-07-04 10:35
诺美新创
http://www.nanosmedical.com/
企业数据由 动脉橙 提供支持
一次性使用介入性医疗器械研产商 | D轮 | 运营中
中国-上海
2021-08-16
云锋基金
查看

According to VCBeat, ENT treatment solution provider Nanos Medical just completed a few million dollars in Series B+ financing, this round of financing was led by Eight Roads Capital.

 

Founded in 2015 and headquartered in Shanghai, Nanos Medical is committed to providing cost-effective otolaryngology medical devices to hospitals through independent research and import. At present, Nanos Medical has many product lines such as otolaryngology diagnosis and treatment equipment, surgical instruments, and interventional consumables.

 

With the influence of air pollution and environmental pollution, there are hundreds of millions of patients in various diseases of ENT in China. Bringing new growth opportunities to the otolaryngology market.

 

Up to now, Nanos Medical has cooperated with Micro Medical, a minimally invasive surgery company in China, and Mega Medical, a provider of medical equipment in Korea. In the future, the three parties will jointly develop the urgently needed treatment plans, improve the quality of medical care, and reduce medical expenses for the patients.

 

>>>>

About Eight Roads Capital


Eight Roads Capital is a venture capital fund, with offices in China, India, Japan and the UK. Eight Roads is the proprietary investment arm of Fidelity International Limited (FIL).

 


相关赛道 其它耗材
文章标签 医疗器械
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

破除招投标不合理限制!千亿医疗市场真的“狼来了”

卷出新高度,投资人去小县城挖掘宝藏医疗项目

直接修复左心室!Ancora Heart研发出全球首款皮下心室修复系统

功能神经外科吸金超过10亿,脑科学领域酝酿新一场范式革命

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

德琪医药新药进展:全新靶点多发性骨髓瘤新药获FDA批准上市

2019-07-04
下一篇

诺华以34亿美元收购武田Xiidra业务,扩展眼科药物产品线

2019-07-04